Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Good
|
New words:
abate, ABIM, Acumen, add, addendum, Aldeyra, alliance, Anne, Aon, Asia, asymptomatic, Athira, attention, attrition, Australia, background, benchmark, Bernardo, bid, BioLine, Biopharma, blend, Brazilian, breakdown, Bribery, capable, Caspi, chair, Chamonix, Chancery, Chicago, choose, Clinician, cohesive, College, Collplant, Colombia, complaint, Compugen, confirmatory, consortium, constitutionality, Corrupt, counsel, cyber, cyberattack, damage, delisted, delisting, Deloitte, departure, depressing, Derovan, devoting, Diasome, difficulty, discontinue, discontinued, dismissed, drop, dropout, dropped, EASD, Edge, electrical, Eliem, engineering, Enlivex, Enochian, EU, fatigue, fewer, fluid, fold, FRCP, Gamida, Gel, GoldenTree, Goldfarb, goodwill, Guaranty, guide, guideline, gym, hand, Head, headed, Houssay, ID, identical, immune, immunogenicity, imperative, inappropriate, inconclusive, incurrence, Indonesia, injury, inside, intrusion, JDRF, Kamada, Kazakhstan, Keck, Korea, Laureate, LLB, Malaysia, malware, media, Medicox, Mexico, Midwest, mild, morale, Netanel, noncompliance, nonpublic, Northwestern, notwithstanding, occasion, offsite, Oman, optimal, Optum, Panel, Pennsylvania, penny, Pharma, plaintiff, PolyPid, possession, predominant, presence, Pritzker, pro, promising, proven, qualitative, Rallybio, rata, Redhill, regain, remeasured, replicate, replicated, Repositioning, reproduce, reputation, reputational, residency, revaluation, round, Rozov, Russia, rx, SAPHRA, satisfactorily, Seligman, Shnida, side, Singapore, slower, Society, Sol, sophistication, Southeast, Southern, speculation, Stanford, stemming, summa, Supreme, Switzerland, Syncora, Tan, telecommunication, Terrace, Thailand, Thanh, top, trademark, trend, Turkey, UBS, UCLA, Ukraine, unanticipated, undertaken, unified, unintended, Union, upheld, Urogen, USC, Uzbekistan, Velocity, Verastem, vi, viability, viable, Vietnam, view, viewed, vii, viii, Viking, VistaGen, VLP, vulnerable, war, weaker, Werewolf, Wharton, workplace, worthwhile, writing, wrongdoing, Yadin, Zomedica
Removed:
absence, acquirer, adjustment, affiliated, aggregated, Ariel, arm, Avraham, BioHealing, bloodstream, Commerce, complement, concept, consumer, DeFronzo, deploying, Diaspora, Discouraging, discrepancy, effort, Emisphere, enable, excellent, extension, flagship, FPG, frequency, Gabay, Gao, glucagon, graduate, Green, HighCape, hypoglycemic, IIb, Impeding, incretin, Incubation, inflammatory, innovator, interaction, investigate, Investigational, Jersey, joining, knowledgeable, leptin, likelihood, Maayan, merger, mineral, Minister, MMTT, modest, move, MSA, Nevada, NIH, nonalcoholic, NY, opposite, overview, partnering, passage, pediatric, pharmacokinetic, physiological, plc, Point, portal, PPG, premier, Prime, proof, Rahway, recommended, recruited, Regenerative, reincorporated, remining, rest, resulted, revolutionizing, Rhythmia, Rosetta, secretion, select, Sharon, Shire, significance, statistically, substantiate, takeover, tender, thrice, tiered, titrated, tolerance, tract, treated, twelve, undergraduate, undiluted, vein, Xiaoming
Filing tables
Filing exhibits
- 10-K Annual report
- 4.4 Description of Securities
- 10.1 Consulting Agreement by and Between Oramed Pharmaceuticals Inc. and Shnida LTD., Entered into As of November 1, 2022, for the Services of Nadav Kidron
- 10.2 Employment Agreement by and Between Oramed LTD. and Nadav Kidron, Entered into As of November 1, 2022
- 10.13 Second Amendment, Dated October 25, 2022, to Employment Agreement, by and Between Oramed LTD. and David Silberman
- 10.14 Representative Form of Indemnification Agreements Between Oramed Pharmaceuticals Inc. and Each of Our Directors and Officers
- 10.23 Form of Restricted Stock Unit Notice and Restricted Stock Unit Agreement
- 10.41 Oravax Medical, Inc. 2021 Long-term Incentive Plan
- 10.42 Oravax Stock Option Agreement
- 23.1 Consent of Kesselman & Kesselman, Independent Registered Public Accounting Firm
- 31.1 Certification
- 31.2 Certification
- 32.1 Certification
- 32.2 Certification
- Download Excel data file
- View Excel data file
ORMP similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (Nos. 333-252696 and 333-257926 and 333-257128) and Form S-8 (Nos. 333-244380, 333-234303, 333-213835, 333-199120, 333-190222, 333-163919 and 333-266105) of Oramed Pharmaceuticals Inc. of our report dated March 6, 2023 relating to the financial statements, which appears in this Form 10-K.
Tel-Aviv, Israel | /S/ Kesselman & Kesselman |
March 6, 2023 | Certified Public Accountants (lsr.) |
A member firm of PricewaterhouseCoopers International Limited |
Kesselman & Kesselman, Derech Menachem Begin 146, Tel-Aviv 6492103, Israel,
P.O Box 7187 Tel-Aviv 6107120 Telephone: +972 -3- 7954555, Fax:+972 -3- 7954556, www.pwc.com/il